Metal‐Organic Framework PCN‐224 Combined Cobalt Oxide Nanoparticles for Hypoxia Relief and Synergistic Photodynamic/Chemodynamic Therapy

Abstract

AbstractPhotodynamic therapy (PDT) and chemodynamic therapy (CDT) are promising tumor treatments mediated by reactive oxygen species (ROS), which have the advantages of being minimally invasive. However, the hypoxia of tumor microenvironment and poor target ability often reduce the therapeutic effect. Here we propose a tumor targeted nanoplatform PCN‐224@Co3O4‐HA for enhanced PDT and synergistic CDT, constructed by hyaluronate‐modified Co3O4 nanoparticles decorated metal‐organic framework PCN‐224. Co3O4 can catalyze the decomposition of highly expressed H2O2 in tumor cells to produce oxygen and alleviate the problem of hypoxia. It can also produce hydroxyl radicals according to the Fenton‐like reaction for chemical dynamic therapy, significantly improving the therapeutic effect. The cell survival experiment showed that after in vitro treatment, 4T1 and MCF‐7 cancer cells died in a large area under the anaerobic state, while the survival ability of normal cell L02 was nearly unchanged. This result effectively indicated that PCN‐224@Co3O4‐HA could effectively relieve tumor hypoxia and improve the effect of PDT and synergistic CDT. Cell uptake experiments showed that PCN‐224@Co3O4‐HA had good targeting properties and could effectively aggregate in tumor cells. In vivo experiments on mice, PCN‐224@Co3O4‐HA presented reliable biosafety performance, and can cooperate with PDT and CDT therapy to prevent the growth of tumor.